JoVE Logo
Faculty Resource Center

Sign In

Patient Derived Cell Culture and Isolation of CD133+ Putative Cancer Stem Cells from Melanoma

DOI :

10.3791/50200-v

March 13th, 2013

March 13th, 2013

20,921 Views

1Institute of Pathology, Laboratory of Molecular Tumor Pathology, Charité - Universitätsmedizin Berlin, 2Institute for Chemistry and Biochemistry, Free University Berlin, 3Laboratory for Functional Genomics Charité (LFGC), Charité - Universitätsmedizin Berlin, 4Comprehensive Cancer Center Charité, Charité - Universitätsmedizin Berlin

This article describes the preparation of freshly obtained melanoma tissue into primary cell cultures, and how to remove contaminations of erythrocytes and fibroblasts from the tumor cells. Finally, we describe how CD133+ putative melanoma stem cells are sorted from the CD133- bulk using Magnetic Activated Cell Sorting (MACS).

Tags

Patient derived Cell Culture

-- Views

Related Videos

article

Ex Vivo Culture of Patient Tissue & Examination of Gene Delivery

article

Isolation of Cardiomyocyte Nuclei from Post-mortem Tissue

article

Isolation, Characterization and Comparative Differentiation of Human Dental Pulp Stem Cells Derived from Permanent Teeth by Using Two Different Methods

article

Time-lapse Imaging of Primary Preneoplastic Mammary Epithelial Cells Derived from Genetically Engineered Mouse Models of Breast Cancer

article

Isolation of Cancer Stem Cells From Human Prostate Cancer Samples

article

Enrichment for Chemoresistant Ovarian Cancer Stem Cells from Human Cell Lines

article

Isolation and Immortalization of Patient-derived Cell Lines from Muscle Biopsy for Disease Modeling

article

Quantitative Mass Spectrometric Profiling of Cancer-cell Proteomes Derived From Liquid and Solid Tumors

article

Studying Pancreatic Cancer Stem Cell Characteristics for Developing New Treatment Strategies

article

Isolation and Culture Expansion of Tumor-specific Endothelial Cells

JoVE Logo

Privacy

Terms of Use

Policies

Research

Education

ABOUT JoVE

Copyright © 2024 MyJoVE Corporation. All rights reserved